Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Wilde

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Drugs|July 1, 1994
Omeprazole. An update of its pharmacology and therapeutic use in acid-related disordersM I Wilde, D McTavish
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Oprelvekin: a review of its pharmacology and therapeutic potential in chemotherapy-induced thrombocytopeniaM I Wilde, D Faulds
Pharmacoeconomics|August 13, 2016
The authors' replyR Davis, M I Wilde
Pharmacoeconomics|July 6, 1998
Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart diseaseA J Coukell, M I Wilde
Drugs|May 11, 1999
Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasiaM I Wilde, K L Goa
Drugs|October 20, 1998
Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugsH D Langtry, M I Wilde
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Lepirudin: a review of its potential place in the management of thrombotic disordersJ C Adkins, M I Wilde
Drugs|June 1, 1996
EbrotidineS S Patel, M I Wilde
Drugs|January 1, 1997
DiacereinC M Spencer, M I Wilde
Drugs|May 1, 1996
Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejectionM I Wilde, K L Goa
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Drugs|July 1, 1994
Omeprazole. An update of its pharmacology and therapeutic use in acid-related disordersM I Wilde, D McTavish
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Oprelvekin: a review of its pharmacology and therapeutic potential in chemotherapy-induced thrombocytopeniaM I Wilde, D Faulds
Pharmacoeconomics|August 13, 2016
The authors' replyR Davis, M I Wilde
Pharmacoeconomics|July 6, 1998
Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart diseaseA J Coukell, M I Wilde
Drugs|May 11, 1999
Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasiaM I Wilde, K L Goa
Drugs|October 20, 1998
Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugsH D Langtry, M I Wilde
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Lepirudin: a review of its potential place in the management of thrombotic disordersJ C Adkins, M I Wilde
Drugs|June 1, 1996
EbrotidineS S Patel, M I Wilde
Drugs|January 1, 1997
DiacereinC M Spencer, M I Wilde
Drugs|May 1, 1996
Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejectionM I Wilde, K L Goa
Pageof 4